Catheter ablation of atrial fibrillation in the elderly

Current Opinion in Cardiology

Volumn 26, Issue 1, 2011, Pages 25-29

  Williamsa, Eric S ^a   Hallb, Burr ^b   Traubb, Darren ^b   Bahnsona, Tristram ^a   Hranitzkya, Patrick ^a   Zarebab, Wojciech ^b   Daubert, James P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antiarrhythmics; Atrial fibrillation; Catheter ablation; Elderly

Indexed keywords

AGED; ARTICLE; CATHETER ABLATION; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RHYTHM; HUMAN; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; STROKE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 79951681871     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283413978     Document Type: Article

References (30)

1. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114:e257-e354.
2. Hurwitz JL. Atrial fibrillation treatment in the elderly: are we getting closer to an answer? J Cardiovasc Electrophysiol 2008; 19:812-814. (Pubitemid 352032792)
3. Rich MW. Epidemiology of atrial fibrillation. J Interv Card Electrophysiol 2009; 25:3-8.
4. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention - the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001; 285:2370-2375. (Pubitemid 32424106)
5. Curtis AB, Rich MW. Atrial fibrillation in the elderly: mechanisms and management. Heart Rhythm 2007; 4:1577-1579. (Pubitemid 350187684)
6. Fang MC. Antithrombotic therapy for the treatment of atrial fibrillation in the elderly. J Interv Card Electrophysiol 2009; 25:19-23.
7. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825-1833. (Pubitemid 35417773)
8. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004; 109:1509-1513. (Pubitemid 38420179)
9. Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009; 360:668-678.
10. Le Heuzey JY, De Ferrari GM, Radzik D, et al. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol 2010; 21:597-605.
11. Piccini JP, Hasselblad V, Peterson ED, et al. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 2009; 54:1089-1095.
12. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study. J Am Coll Cardiol 2006; 48:2340-2347. (Pubitemid 44856763)
13. Stabile G, Bertaglia E, Senatore G, et al. Feasibility of pulmonary vein ostia radiofrequency ablation in patients with atrial fibrillation: a multicenter study (CACAF pilot study). Pacing Clin Electrophysiol 2003; 26:284-287. (Pubitemid 36399156)
14. Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010; 303:333-340.
15. Crandall MA, Bradley DJ, Packer DL, Asirvatham SJ. Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc 2009; 84:643-662.
16. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4:816-861. (Pubitemid 46850611)
17. Bhargava M, Marrouche NF, Martin DO, et al. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter. J Cardiovasc Electrophysiol 2004; 15:8-13. (Pubitemid 38152966)
18. Traub D, Daubert JP, McNitt S, et al. Catheter ablation of atrial fibrillation in the elderly: where do we stand? Cardiol J 2009; 16:113-120.
19. Hsieh MH, Tai CT, Lee SH, et al. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2005; 16:457-461.
20. Zado E, Callans DJ, Riley M, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol 2008; 19:621-626. (Pubitemid 351858428)
21. Corrado A, Patel D, Riedlbauchova L, et al. Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians. J Cardiovasc Electrophysiol 2008; 19:807-811. (Pubitemid 352032783)
22. Nademanee K, Schwab MC, Kosar EM, et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 2008; 51:843-849. (Pubitemid 351253744)
23. Kusumoto F, Prussak K, Wiesinger M, et al. Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications. J Interv Card Electrophysiol 2009; 25:31-35.
24. Bunch TJ, Weiss JP, Crandall BG, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol 2010; 33:146-152.
25. Yamada T, Kay GN. Catheter ablation of atrial fibrillation in the elderly. Pacing Clin Electrophysiol 2009; 32:1085-1091.
26. Yu CM, Chan JY, Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009; 361:2123-2134.
27. Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol 2008; 19:627-631. (Pubitemid 351832292)
28. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3:32-38.
29. Tzou WS, Marchlinski FE, Zado ES, et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3:237-242.
30. Wokhlu A, Hodge DO, Monahan KH, et al. Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol 2010; 21:1071-1078.